Logo for Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Investor Relations Material

Latest events

Logo for Rani Therapeutics Holdings Inc

Investor Update

Rani Therapeutics Holdings
Logo for Rani Therapeutics Holdings

Q3 2024

14 Nov, 2024
Logo for Rani Therapeutics Holdings

Q2 2024

6 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Rani Therapeutics Holdings Inc

Access all reports
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company primarily focused on the development of innovative technologies for the oral delivery of biologics. The company's flagship technology, the RaniPill capsule, represents a novel, proprietary platform designed to administer biologic drugs orally that would typically be delivered via injection. This technology aims to improve patient outcomes by making treatment more accessible and less invasive. Rani Therapeutics is exploring the potential of its platform across a range of drug substances, including peptides, proteins, and antibodies, with applications in various therapeutic areas. The company is headquartered in San Jose, California, and its shares are listed on the Nasdaq.